Kinetics of aspartic acid isomerization and enantiomerization in model aspartyl tripeptides under forced conditions

Journal of Pharmaceutical Sciences

Volumn 99, Issue 10, 2010, Pages 4162-4173

  Conrad, Uwe ^a   Fahr, Alfred ^a   Scriba, Gerhard K E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Aspartic acid; Aspartyl peptide; Capillary electrophoresis; Deamidation; Enantiomerization; Isoaspartic acid; Isomerization; Kinetics; Peptides; Stability

Indexed keywords

ASPARAGINE; ASPARTIC ACID; ASPARTIC ACID DERIVATIVE; SUCCINIMIDE; TRIPEPTIDE;

AMINO ACID ANALYSIS; ARTICLE; CAPILLARY ELECTROPHORESIS; DIASTEREOISOMER; ENANTIOMER; ISOMERIZATION; STEREOCHEMISTRY;

EID: 77957372613     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22134     Document Type: Article

References (37)

1. Aswad DW, editor. 1995. Deamidation and isoaspartate formation in peptides and proteins. Boca Raton, FL: CRC Press. p 279.
2. Robinson NE, Robinson AB. 2004. Molecular clocks. Cave Junction: Althouse Press. p 419.
3. Capasso S, Kirby AJ, Salvadori S, Sica F, Zagari A. 1995. Kinetics and mechanism of the reversible isomerization of aspartic-acid residues in tetrapeptides. J Chem Soc Perkin Trans 2:437-442.
4. Stephenson RC, Clarke S. 1989. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem 264:6164-6170.
5. Geiger T, Clarke S. 1987. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides - Succinimide-linked reactions that contribute to protein-degradation. J Biol Chem 262:785-794.
6. Oliyai C, Borchardt RT. 1994. Chemical pathways of peptide degradation. 6. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides. Pharm Res 11:751-758.
7. Patel K, Borchardt RT. 1990. Chemical pathways of peptide degradation. 3. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. Pharm Res 7:787-793.
8. Oliyai C, Borchardt RT. 1993. Chemical pathways of peptide degradation. 4. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharm Res 10:95-102.
9. Radkiewicz JL, Zipse H, Clarke S, Houk KN. 2001. Neighboring side chain effects on asparaginyl and aspartyl degradation: An ab initio study of the relationship between peptide conformation and backbone NH acidity. J Am Chem Soc 123:3499-3506.
10. Wakankar AA, Borchardt RT. 2006. Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. J Pharm Sci 95:2321-2336.
11. Lura R, Schirch V. 1988. Role of peptide conformation in the rate and mechanism of deamidation of asparaginyl residues. Biochemistry 27:7671-7677.
12. Xie M, Schowen RL. 1999. Secondary structure and protein deamidation. J Pharm Sci 88:8-13.
13. Athmer L, Kindrachuk J, Georges F, Napper S. 2002. The influence of protein structure on the products emerging from succinimide hydrolysis. J Biol Chem 277:30502-30507.
14. Capasso S, Mazzarella L, Zagari A. 1991. Deamidation via cyclic imide of asparaginyl peptides: Dependence on salts buffers, and organic solvents. Pept Res 4:234-238.
15. Tam JP, Riemen MW, Merrifield RB. 1988. Mechanisms of aspartimide formation: The effects of protecting groups, acid, base, temperature and time. Pept Res 1:6-18.
16. Radkiewicz JL, Zipse H, Clarke S, Houk KN. 1996. Accelerated racemization of aspartic acid and asparagine residues via succinimide intermediates: An ab initio theoretical exploration of mechanism. J Am Chem Soc 118:9148-9155.
17. Li B, Borchardt RT, Topp EM, Vander Velde D, Schowen RL. 2003. Racemization of an asparagine residue during peptide deamidation. J Am Chem Soc 125:11486-11487.
18. Ritz-Timme S, Collins MJ. 2002. Racemization of aspartic acid in human proteins. Ageing Res Rev 1:43-59.
19. Bada JL. 1984. In vivo racemization in mammalian proteins. Methods Enzymol 106:98-115.
20. Manning MC, Patel K, Borchardt RT. 1989. Stability of protein pharmaceuticals. Pharm Res 6:903-918.
21. Orpiszewski J, Schormann N, Kluve-Beckerman B, Liepnieks JJ, Benson MD. 2000. Protein aging hypothesis of Alzheimer disease. FASEB J 14:1255-1263.
22. Tomiyama T, Asano S, Furiya Y, Shirasawa T, Endo N, Mori H. 1994. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. J Biol Chem 269:10205-10208.
23. Fischer GH, Payan IL, Chou SJ, Man EH, Cerwinski S, Martin T, Emory C, Frey WH. 1992. Racemized D-aspartate in Alzheimer neurofibrillary tangles. Brain Res Bull 28:127-131.
24. Fujii N, Momose Y, Harada K. 1996. Kinetic study of racemization of aspartyl residues in model peptides of alpha-A-crystalline. Int J Pept Protein Res 48:118-122.
25. Fujii N, Ishibashi Y, Satoh K, Fujino M, Harada K. 1994. Simultaneous racemization and isomerization at specific aspartic-acid residues in alpha-B-crystallin from the aged human lens. Biochim Biophys Acta Protein Struct Mol Enzymol 1204:157-163. (Pubitemid 24074841)
26. Fujii N, Tajima S, Tanaka N, Fujimoto N, Takata T, Shimo-Oka T. 2002. The presence of D-beta-aspartic acid-containing peptides in elastic fibers of sun-damaged skin: A potent marker for ultraviolet-induced skin aging. Biochem Biophys Res Commun 294:1047-1051.
27. Kuge K, Fujii N, Miura Y, Tajima S, Saito T. 2004. Kinetic study of racemization of aspartyl residues in synthetic elastin peptides. Amino Acids 27:193-197.
28. Cloos PA, Fledelius C. 2000. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: A biological clock of protein aging with clinical potential. Biochem J 345:473-480.
29. Won CM, Molnar TE, Windisch VL, McKean RE. 1999. Kinetics and mechanism of degradation of klerval, a pseudo-tetrapeptide. Int J Pharm 190:1-11.
30. De Boni S, Oberthür C, Hamburger M, Scriba GKE. 2004. Analysis of aspartyl peptide degradation products by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry. J Chromatogr A 1022:95-102.
31. De Boni S, Scriba GKE. 2007. Capillary electrophoresis analysis of hydrolysis, isomerization and enantiomerization of aspartyl model tripeptides in acidic and alkaline solution. J Pharm Biomed Anal 43:49-56.
32. DeHart MP, Anderson BD. 2007. The role of the cyclic imide in alternate degradation pathways for asparagine-containing peptides and proteins. J Pharm Sci 96:2667-2685.
33. Schön I, Kisfaludy L. 1979. Formation of aminosuccinyl peptides during acidolytic deprotection followed by their transformation to piperazine-2,5-dione derivatives in neutral media. Int J Pept Protein Res 14:485-494.
34. Bell BM, Burke JV, Schumitzky A. 1996. A relative weighting method for estimating parameters and variances in multiple data sets. Comput Stat Data Anal 22:119-135.
35. Collins MJ, Waite ER, van Duin ACT. 1999. Predicting protein decomposition: The case of aspartic-acid racemization kinetics. Philos Trans R Soc B 354:51-64.
36. Li B, Schowen RL, Topp EM, Borchardt RT. 2006. Effect of N-1 and N-2 residues on peptide deamidation rate in solution and solid state. AAPS J 8:E166-E173.
37. Tyler-Cross R, Schirch V. 1991. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. J Biol Chem 266:22549-22556.